Synthesis, and biological evaluation of 2-(4-aminophenyl)benzothiazole derivatives as photosensitizing agents

Add time:07/17/2019    Source:sciencedirect.com

Photodynamic therapy (PDT) employing exogenous photosensitizers is currently being approved for treatment of basal cell carcinoma (BCC). 2-(4-Aminophenyl)benzothiazoles (6) consist of chromophoric structure and absorb light in the UVA (315–400 nm). These results encouraged us to design and synthesize a diversity of 2-phenylbenzothiazoles (6). Studies on the apoptotic mechanism involved in photosensitive effects induced by UVA-activated 6 in BCC cells are carried out in the present article. 6-UVA-treated cells displayed several features of apoptosis, including an increase in the sub-G1 population, a significantly increased annexin V binding, and activation of caspase-3. 6-UVA induced a decrease in mitochondrial membrane potential (Δψmt) and ATP via enhanced ROS generation and promoted phosphorylation of extracellular signal-regulated kinase (ERK) and p38 MAPK expression. These results suggest that 6-UVA elicits photosensitive effects in mitochondria processes which involve ERK and p38 activation, and ultimately lead to BCC cell apoptosis.

We also recommend Trading Suppliers and Manufacturers of 2-(4-Aminophenyl)-6-methyl-1,3-benzothiazole-7-sulfonic acid (cas 130-17-6). Pls Click Website Link as below: cas 130-17-6 suppliers

Prev:Synthesis and electropolymerization of tetra-[β-(2-benzimidazole)] and tetra-[β-(2-(1-(4- aminophenyl))benzimidazole)] embedded cobalt phthalocyanine and their supercapacitance behaviour
Next:Clinical available circulating tumor cell assay based on tetra(4-aminophenyl) porphyrin mediated reduced graphene oxide field effect transistor)